Dec 2023

PharmaBioSource Advises Lubrizol on the Sale of Particle Sciences to Agno Pharma

Lubrizol – Particle Sciences Transaction

PharmaBioSource provided exclusive consulting services to Lubrizol on the divestment of its contract development and manufacturing subsidiary, Particle Sciences, to Agno Pharma.

  • Service: Consulting
  • Sector: Pharmaceuticals
  • Sub-sector: Sterile Injectables and Other Drug Product Formulation Development CDMO
  • Engagement Type: Sell Side

PharmaBioSource assisted Lubrizol to divest Particle Sciences, a Bethlehem, PA-based specialty drug product formulation development business and its 50,000 SF laboratory and clinical manufacturing facility which also housed a brand new sterile injectable filling suite. Agno Pharma acquired Particle Sciences in a fast-paced transaction process of only three months.

PharmaBioSource’s services included buyer target identification, creation of the confidential information memorandum (CIM), marketing, data room and due diligence support.

Press Release